focus -WSS

focus

author：fashion 2025-08-12 08:28:02 - browse：9515

ITeos Therapeutics offered the first look at clinical data for its experimental cancer antibody that works by blocking the novel — and very buzzworthy — protein target called TIGIT.

The tumor-shrinking activity of the company’s drug, called EOS-448, was minimal but still comparable to early study data from competing TIGIT-targeted drugs in development, including ones from Roche and Merck.

iTeos presented the EOS-448 Phase 1 study results at the annual meeting of the American Association for Cancer Research on Saturday.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Driven by the pandemic, applicants flood public health schools

focus

WSS

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Why Congress must ban federal programs from using QALYs

Biotech companies concerned about China biosecurity crackdown

Stanford president's case begs question: Who takes blame?

Affordable Connectivity Program vital to health care, experts say

Wikipedia

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Continuity nursing helped my family in our darkest PICU moments

7 more heat

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Indian pharmaceutical industry in denial over drug

Heart attack and stroke risk calculators need revising

Covid isolation guidance eased by the CDC

Guidelines to prevent youth baseball injuries need more muscle

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

ChatGPT in medicine: STAT answers readers' burning questions

Mass General totes up its waste in a move to tackle climate change

entertainment

ALS groups 'won't be played again' by the FDA, drug sponsors

FogPharma raises $145 million in rare Series E round

Stanford president faces new allegations over 1999 paper

Why Congress must ban federal programs from using QALYs

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Texas Department of Public Safety speaks out on migrant abuse allegations

hotspot

hotspot

focus

entertainment